ID   CNOT1_HUMAN             Reviewed;        2376 AA.
AC   A5YKK6; Q68DX7; Q7Z3K2; Q8IWB8; Q8TB53; Q9BVZ6; Q9UFR8; Q9UI27;
AC   Q9Y2L0;
DT   15-JAN-2008, integrated into UniProtKB/Swiss-Prot.
DT   15-JAN-2008, sequence version 2.
DT   22-JUL-2015, entry version 82.
DE   RecName: Full=CCR4-NOT transcription complex subunit 1;
DE   AltName: Full=CCR4-associated factor 1;
DE   AltName: Full=Negative regulator of transcription subunit 1 homolog;
DE            Short=NOT1H;
DE            Short=hNOT1;
GN   Name=CNOT1; Synonyms=CDC39, KIAA1007, NOT1; ORFNames=AD-005;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 244-2376 (ISOFORM 1).
RC   TISSUE=Cervix, Fetal kidney, and Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 757-2376 (ISOFORM 1), AND VARIANT
RP   ALA-603.
RC   TISSUE=Choriocarcinoma, Leiomyosarcoma, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 537-2376 (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=10231032; DOI=10.1093/dnares/6.1.63;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M.,
RA   Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIII.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 6:63-70(1999).
RN   [5]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1964-2374 (ISOFORM 1).
RC   TISSUE=Adrenal gland;
RX   PubMed=10931946; DOI=10.1073/pnas.160270997;
RA   Hu R.-M., Han Z.-G., Song H.-D., Peng Y.-D., Huang Q.-H., Ren S.-X.,
RA   Gu Y.-J., Huang C.-H., Li Y.-B., Jiang C.-L., Fu G., Zhang Q.-H.,
RA   Gu B.-W., Dai M., Mao Y.-F., Gao G.-F., Rong R., Ye M., Zhou J.,
RA   Xu S.-H., Gu J., Shi J.-X., Jin W.-R., Zhang C.-K., Wu T.-M.,
RA   Huang G.-Y., Chen Z., Chen M.-D., Chen J.-L.;
RT   "Gene expression profiling in the human hypothalamus-pituitary-adrenal
RT   axis and full-length cDNA cloning.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:9543-9548(2000).
RN   [7]
RP   FUNCTION, INTERACTION WITH CNOT2; CNOT4 AND CNOT8, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=10637334; DOI=10.1093/nar/28.3.809;
RA   Albert T.K., Lemaire M., van Berkum N.L., Gentz R., Collart M.A.,
RA   Timmers H.T.M.;
RT   "Isolation and characterization of human orthologs of yeast CCR4-NOT
RT   complex subunits.";
RL   Nucleic Acids Res. 28:809-817(2000).
RN   [8]
RP   FUNCTION, DOMAIN, AND INTERACTION WITH CNOT2; CNOT3; CNOT8; ESR1 AND
RP   RXRA.
RX   PubMed=16778766; DOI=10.1038/sj.emboj.7601194;
RA   Winkler G.S., Mulder K.W., Bardwell V.J., Kalkhoven E., Timmers H.T.;
RT   "Human Ccr4-Not complex is a ligand-dependent repressor of nuclear
RT   receptor-mediated transcription.";
RL   EMBO J. 25:3089-3099(2006).
RN   [9]
RP   INTERACTION WITH TOB1.
RX   PubMed=18377426; DOI=10.1111/j.1349-7006.2008.00746.x;
RA   Miyasaka T., Morita M., Ito K., Suzuki T., Fukuda H., Takeda S.,
RA   Inoue J., Semba K., Yamamoto T.;
RT   "Interaction of antiproliferative protein Tob with the CCR4-NOT
RT   deadenylase complex.";
RL   Cancer Sci. 99:755-761(2008).
RN   [10]
RP   IDENTIFICATION IN THE CCR4-NOT COMPLEX, AND COMPOSITION OF THE
RP   CCR4-NOT COMPLEX.
RX   PubMed=19558367; DOI=10.1042/BJ20090500;
RA   Lau N.C., Kolkman A., van Schaik F.M., Mulder K.W., Pijnappel W.W.,
RA   Heck A.J., Timmers H.T.;
RT   "Human Ccr4-Not complexes contain variable deadenylase subunits.";
RL   Biochem. J. 422:443-453(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   INTERACTION WITH TNRC6A; TNRC6B AND TNRC6C.
RX   PubMed=21981923; DOI=10.1016/j.molcel.2011.09.007;
RA   Braun J.E., Huntzinger E., Fauser M., Izaurralde E.;
RT   "GW182 proteins directly recruit cytoplasmic deadenylase complexes to
RT   miRNA targets.";
RL   Mol. Cell 44:120-133(2011).
RN   [13]
RP   FUNCTION, AND INTERACTION WITH TNRC6C.
RX   PubMed=21984185; DOI=10.1038/nsmb.2149;
RA   Fabian M.R., Cieplak M.K., Frank F., Morita M., Green J., Srikumar T.,
RA   Nagar B., Yamamoto T., Raught B., Duchaine T.F., Sonenberg N.;
RT   "miRNA-mediated deadenylation is orchestrated by GW182 through two
RT   conserved motifs that interact with CCR4-NOT.";
RL   Nat. Struct. Mol. Biol. 18:1211-1217(2011).
RN   [14]
RP   FUNCTION, AND INTERACTION WITH ZFP36.
RX   PubMed=21278420; DOI=10.1093/nar/gkr011;
RA   Sandler H., Kreth J., Timmers H.T., Stoecklin G.;
RT   "Not1 mediates recruitment of the deadenylase Caf1 to mRNAs targeted
RT   for degradation by tristetraprolin.";
RL   Nucleic Acids Res. 39:4373-4386(2011).
RN   [15]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=21976065; DOI=10.1007/s13238-011-1092-4;
RA   Ito K., Takahashi A., Morita M., Suzuki T., Yamamoto T.;
RT   "The role of the CNOT1 subunit of the CCR4-NOT complex in mRNA
RT   deadenylation and cell viability.";
RL   Protein Cell 2:755-763(2011).
RN   [16]
RP   FUNCTION, AND DEVELOPMENTAL STAGE.
RX   PubMed=22367759; DOI=10.1002/stem.1070;
RA   Zheng X., Dumitru R., Lackford B.L., Freudenberg J.M., Singh A.P.,
RA   Archer T.K., Jothi R., Hu G.;
RT   "Cnot1, Cnot2, and Cnot3 maintain mouse and human ESC identity and
RT   inhibit extraembryonic differentiation.";
RL   Stem Cells 30:910-922(2012).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 1093-1317 IN COMPLEX WITH
RP   CNOT7, INTERACTION WITH CNOT8; CNOT6 AND CNOT6L, AND MUTAGENESIS OF
RP   LYS-1208; HIS-1212 AND LYS-1218.
RX   PubMed=22977175; DOI=10.1093/nar/gks883;
RA   Petit A.P., Wohlbold L., Bawankar P., Huntzinger E., Schmidt S.,
RA   Izaurralde E., Weichenrieder O.;
RT   "The structural basis for the interaction between the CAF1 nuclease
RT   and the NOT1 scaffold of the human CCR4-NOT deadenylase complex.";
RL   Nucleic Acids Res. 40:11058-11072(2012).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) OF 800-1004 IN COMPLEX WITH
RP   ZFP36, INTERACTION WITH ZFP36, AND FUNCTION.
RX   PubMed=23644599; DOI=10.1038/nsmb.2572;
RA   Fabian M.R., Frank F., Rouya C., Siddiqui N., Lai W.S., Karetnikov A.,
RA   Blackshear P.J., Nagar B., Sonenberg N.;
RT   "Structural basis for the recruitment of the human CCR4-NOT
RT   deadenylase complex by tristetraprolin.";
RL   Nat. Struct. Mol. Biol. 20:735-739(2013).
CC   -!- FUNCTION: Scaffolding component of the CCR4-NOT complex which is
CC       one of the major cellular mRNA deadenylases and is linked to
CC       various cellular processes including bulk mRNA degradation, miRNA-
CC       mediated repression, translational repression during translational
CC       initiation and general transcription regulation. Additional
CC       complex functions may be a consequence of its influence on mRNA
CC       expression. Its scaffolding function implies its interaction with
CC       the catalytic complex module and diverse RNA-binding proteins
CC       mediating the complex recruitment to selected mRNA 3'UTRs.
CC       Involved in degradation of AU-rich element (ARE)-containing mRNAs
CC       probably via association with ZFP36. Mediates the recruitment of
CC       the CCR4-NOT complex to miRNA targets and to the RISC complex via
CC       association with TNRC6A, TNRC6B or TNRC6C. Acts as a
CC       transcriptional repressor. Represses the ligand-dependent
CC       transcriptional activation by nuclear receptors. Involved in the
CC       maintenance of emryonic stem (ES) cell identity.
CC       {ECO:0000269|PubMed:10637334, ECO:0000269|PubMed:16778766,
CC       ECO:0000269|PubMed:21278420, ECO:0000269|PubMed:21976065,
CC       ECO:0000269|PubMed:21984185, ECO:0000269|PubMed:22367759,
CC       ECO:0000269|PubMed:23644599}.
CC   -!- SUBUNIT: Component of the CCR4-NOT complex; distinct complexes
CC       seem to exist that differ in the participation of probably
CC       mutually exclusive catalytic subunits. In the complex, interacts
CC       directly with CNOT6, CNOT6L, CNOT7 or CNOT8. Interacts in a
CC       ligand-dependent fashion with ESR1 and RXRA. Interacts with
CC       NANOS2, TOB1 and ZFP36. Interacts with TNRC6A, TNRC6B or TNRC6C;
CC       the interactions are direct. {ECO:0000269|PubMed:10637334,
CC       ECO:0000269|PubMed:16778766, ECO:0000269|PubMed:18377426,
CC       ECO:0000269|PubMed:19558367, ECO:0000269|PubMed:21278420,
CC       ECO:0000269|PubMed:21981923, ECO:0000269|PubMed:21984185,
CC       ECO:0000269|PubMed:22977175, ECO:0000269|PubMed:23644599}.
CC   -!- INTERACTION:
CC       Q9UKZ1:CNOT11; NbExp=3; IntAct=EBI-1222758, EBI-2562014;
CC       Q9NZN8:CNOT2; NbExp=3; IntAct=EBI-1222758, EBI-743033;
CC       Q9ULM6:CNOT6; NbExp=2; IntAct=EBI-1222758, EBI-2104530;
CC       Q96LI5:CNOT6L; NbExp=2; IntAct=EBI-1222758, EBI-1046635;
CC       Q9UIV1:CNOT7; NbExp=6; IntAct=EBI-1222758, EBI-2105113;
CC       Q9UFF9:CNOT8; NbExp=5; IntAct=EBI-1222758, EBI-742299;
CC       Q8NDV7:TNRC6A; NbExp=2; IntAct=EBI-1222758, EBI-2269715;
CC       Q9UPQ9:TNRC6B; NbExp=4; IntAct=EBI-1222758, EBI-947158;
CC       Q9HCJ0:TNRC6C; NbExp=6; IntAct=EBI-1222758, EBI-6507625;
CC       P50616:TOB1; NbExp=3; IntAct=EBI-1222758, EBI-723281;
CC       P22893:Zfp36 (xeno); NbExp=5; IntAct=EBI-1222758, EBI-647803;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, P-body
CC       {ECO:0000269|PubMed:21976065}. Nucleus
CC       {ECO:0000305|PubMed:21976065}. Note=NANOS2 promotes its
CC       localization to P-body. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=A5YKK6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=A5YKK6-2; Sequence=VSP_030559;
CC       Name=3;
CC         IsoId=A5YKK6-3; Sequence=VSP_030559, VSP_030562, VSP_030563;
CC       Name=4;
CC         IsoId=A5YKK6-4; Sequence=VSP_030560, VSP_030561;
CC   -!- TISSUE SPECIFICITY: Strongly expressed in brain, heart, thymus,
CC       spleen, kidney, liver, placenta and lung. Weakly expressed in
CC       skeletal muscle and colon. {ECO:0000269|PubMed:10637334}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in embryonic stem (ES) cells.
CC       {ECO:0000269|PubMed:22367759}.
CC   -!- DOMAIN: Contains Leu-Xaa-Xaa-Leu-Leu (LXXLL) motifs, a motif known
CC       to be important for the association with nuclear receptors.
CC       {ECO:0000269|PubMed:16778766}.
CC   -!- SIMILARITY: Belongs to the CNOT1 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF14861.1; Type=Frameshift; Positions=1969, 2273; Evidence={ECO:0000305};
CC       Sequence=CAH18093.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL117492; CAB55960.1; -; mRNA.
DR   EMBL; BX537840; CAD97851.1; -; mRNA.
DR   EMBL; CR749237; CAH18093.1; ALT_INIT; mRNA.
DR   EMBL; EF553522; ABQ66268.1; -; mRNA.
DR   EMBL; AC009118; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC010287; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000779; AAH00779.2; -; mRNA.
DR   EMBL; BC024317; AAH24317.1; -; mRNA.
DR   EMBL; BC040523; AAH40523.1; -; mRNA.
DR   EMBL; AB023224; BAA76851.2; -; mRNA.
DR   EMBL; AF110778; AAF14861.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS10799.1; -. [A5YKK6-1]
DR   CCDS; CCDS45501.1; -. [A5YKK6-4]
DR   CCDS; CCDS58468.1; -. [A5YKK6-2]
DR   PIR; T17270; T17270.
DR   RefSeq; NP_001252541.1; NM_001265612.1. [A5YKK6-2]
DR   RefSeq; NP_057368.3; NM_016284.4. [A5YKK6-1]
DR   RefSeq; NP_996882.1; NM_206999.2. [A5YKK6-4]
DR   UniGene; Hs.460923; -.
DR   UniGene; Hs.731691; -.
DR   PDB; 4C0D; X-ray; 3.20 A; A=1565-2371.
DR   PDB; 4CQO; X-ray; 2.80 A; A/C=1833-2361.
DR   PDB; 4CRU; X-ray; 1.65 A; A=1356-1607.
DR   PDB; 4CRV; X-ray; 2.05 A; A=1356-1607.
DR   PDB; 4CRW; X-ray; 1.75 A; A=1093-1317.
DR   PDB; 4CT4; X-ray; 2.30 A; A/C=1063-1314.
DR   PDB; 4CT6; X-ray; 2.10 A; A=1352-1594.
DR   PDB; 4CT7; X-ray; 1.90 A; A=1352-1594.
DR   PDB; 4GMJ; X-ray; 2.70 A; A/C/E=1093-1317.
DR   PDB; 4GML; X-ray; 2.90 A; A/B/C/D/E/F=1093-1317.
DR   PDB; 4J8S; X-ray; 1.55 A; A=800-1004.
DR   PDBsum; 4C0D; -.
DR   PDBsum; 4CQO; -.
DR   PDBsum; 4CRU; -.
DR   PDBsum; 4CRV; -.
DR   PDBsum; 4CRW; -.
DR   PDBsum; 4CT4; -.
DR   PDBsum; 4CT6; -.
DR   PDBsum; 4CT7; -.
DR   PDBsum; 4GMJ; -.
DR   PDBsum; 4GML; -.
DR   PDBsum; 4J8S; -.
DR   ProteinModelPortal; A5YKK6; -.
DR   SMR; A5YKK6; 827-1004, 1069-1310, 1352-1588, 1842-2353.
DR   BioGrid; 116660; 43.
DR   DIP; DIP-44954N; -.
DR   IntAct; A5YKK6; 38.
DR   MINT; MINT-3084598; -.
DR   STRING; 9606.ENSP00000320949; -.
DR   PhosphoSite; A5YKK6; -.
DR   BioMuta; CNOT1; -.
DR   MaxQB; A5YKK6; -.
DR   PaxDb; A5YKK6; -.
DR   PeptideAtlas; A5YKK6; -.
DR   PRIDE; A5YKK6; -.
DR   Ensembl; ENST00000317147; ENSP00000320949; ENSG00000125107.
DR   Ensembl; ENST00000441024; ENSP00000413113; ENSG00000125107. [A5YKK6-4]
DR   Ensembl; ENST00000567188; ENSP00000456649; ENSG00000125107. [A5YKK6-3]
DR   Ensembl; ENST00000569240; ENSP00000455635; ENSG00000125107. [A5YKK6-2]
DR   GeneID; 23019; -.
DR   KEGG; hsa:23019; -.
DR   UCSC; uc002enu.5; human. [A5YKK6-2]
DR   UCSC; uc002env.4; human. [A5YKK6-1]
DR   UCSC; uc002enx.4; human. [A5YKK6-4]
DR   CTD; 23019; -.
DR   GeneCards; GC16M058553; -.
DR   H-InvDB; HIX0013093; -.
DR   HGNC; HGNC:7877; CNOT1.
DR   HPA; HPA046577; -.
DR   HPA; HPA049664; -.
DR   MIM; 604917; gene.
DR   neXtProt; NX_A5YKK6; -.
DR   PharmGKB; PA26672; -.
DR   eggNOG; COG5103; -.
DR   GeneTree; ENSGT00390000014869; -.
DR   HOVERGEN; HBG060834; -.
DR   InParanoid; A5YKK6; -.
DR   KO; K12604; -.
DR   OMA; DSAYTHY; -.
DR   OrthoDB; EOG744T85; -.
DR   PhylomeDB; A5YKK6; -.
DR   TreeFam; TF105630; -.
DR   Reactome; REACT_20514; Deadenylation of mRNA.
DR   ChiTaRS; CNOT1; human.
DR   GeneWiki; CNOT1; -.
DR   GenomeRNAi; 23019; -.
DR   NextBio; 43960; -.
DR   PRO; PR:A5YKK6; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; A5YKK6; -.
DR   ExpressionAtlas; A5YKK6; baseline and differential.
DR   Genevisible; A5YKK6; HS.
DR   GO; GO:0030014; C:CCR4-NOT complex; IDA:UniProtKB.
DR   GO; GO:0000932; C:cytoplasmic mRNA processing body; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005778; C:peroxisomal membrane; IDA:UniProtKB.
DR   GO; GO:0070016; F:armadillo repeat domain binding; IPI:BHF-UCL.
DR   GO; GO:0030331; F:estrogen receptor binding; IDA:UniProtKB.
DR   GO; GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB.
DR   GO; GO:0032947; F:protein complex scaffold; IDA:BHF-UCL.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:BHF-UCL.
DR   GO; GO:0042974; F:retinoic acid receptor binding; IDA:UniProtKB.
DR   GO; GO:0010467; P:gene expression; TAS:Reactome.
DR   GO; GO:0035195; P:gene silencing by miRNA; IDA:BHF-UCL.
DR   GO; GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW.
DR   GO; GO:0033147; P:negative regulation of intracellular estrogen receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0048387; P:negative regulation of retinoic acid receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   GO; GO:0017148; P:negative regulation of translation; IDA:BHF-UCL.
DR   GO; GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome.
DR   GO; GO:0000289; P:nuclear-transcribed mRNA poly(A) tail shortening; TAS:Reactome.
DR   GO; GO:0010606; P:positive regulation of cytoplasmic mRNA processing body assembly; IDA:UniProtKB.
DR   GO; GO:0061014; P:positive regulation of mRNA catabolic process; IMP:BHF-UCL.
DR   GO; GO:1900153; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; IMP:UniProtKB.
DR   GO; GO:0060213; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; IMP:UniProtKB.
DR   GO; GO:2000036; P:regulation of stem cell maintenance; IMP:UniProtKB.
DR   GO; GO:0090503; P:RNA phosphodiester bond hydrolysis, exonucleolytic; IDA:GOC.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   InterPro; IPR007196; CCR4-Not_Not1_C.
DR   InterPro; IPR024557; CCR4-Not_Not1su_DUF3819.
DR   Pfam; PF12842; DUF3819; 1.
DR   Pfam; PF04054; Not1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   Developmental protein; Nucleus; Polymorphism; Reference proteome;
KW   Repressor; RNA-mediated gene silencing; Transcription;
KW   Transcription regulation; Translation regulation.
FT   CHAIN         1   2376       CCR4-NOT transcription complex subunit 1.
FT                                /FTId=PRO_0000315541.
FT   REGION      800   1015       Interaction with ZFP36.
FT   REGION     1090   1605       Interaction with CNOT6, CNOT6L, CNOT7 and
FT                                CNOT8.
FT   MOTIF       153    157       LXXLL.
FT   MOTIF       181    185       LXXLL.
FT   MOTIF       223    227       LXXLL.
FT   MOTIF       570    574       LXXLL.
FT   MOTIF      1639   1643       LXXLL.
FT   MOTIF      1942   1946       LXXLL.
FT   MOTIF      2096   2100       LXXLL.
FT   COMPBIAS   1333   1350       Thr-rich.
FT   VAR_SEQ     822    827       SKMKPS -> T (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:10231032,
FT                                ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_030559.
FT   VAR_SEQ    1479   1551       TASPQQREMMDQAAAQLAQDNCELACCFIQKTAVEKAGPEM
FT                                DKRLATEFELRKHARQEGRRYCDPVVLTYQAE -> VSWLF
FT                                PWYRYKTYYCLSVIIFFFVYIWHWALPLILNNHHICLMSSI
FT                                ILDCNSVRQSIMSVCFFFFLLYSQHDV (in isoform
FT                                4). {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_030560.
FT   VAR_SEQ    1552   2376       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_030561.
FT   VAR_SEQ    2152   2155       VDML -> SLTL (in isoform 3).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_030562.
FT   VAR_SEQ    2156   2376       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_030563.
FT   VARIANT     603    603       D -> A (in dbSNP:rs17854028).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_038254.
FT   MUTAGEN    1208   1208       K->E: Impairs interaction with CNOT7;
FT                                when associated with Y-1212 and E-1218.
FT                                {ECO:0000269|PubMed:22977175}.
FT   MUTAGEN    1209   1209       P->Y: Abolishes interaction with CNOT7;
FT                                when associated with Y-1257.
FT   MUTAGEN    1212   1212       H->Y: Impairs interaction with CNOT7;
FT                                when associated with E-1208 and E-1218.
FT                                {ECO:0000269|PubMed:22977175}.
FT   MUTAGEN    1218   1218       K->E: Impairs interaction with CNOT7;
FT                                when associated with E-1208 and Y-1212.
FT                                {ECO:0000269|PubMed:22977175}.
FT   MUTAGEN    1251   1251       V->R: Abolishes interaction with CNOT7.
FT   MUTAGEN    1257   1257       P->Y: Abolishes interaction with CNOT7;
FT                                when associated with Y-1209.
FT   CONFLICT     18     18       D -> G (in Ref. 1; CAD97851).
FT                                {ECO:0000305}.
FT   CONFLICT    323    323       D -> G (in Ref. 1; CAD97851).
FT                                {ECO:0000305}.
FT   CONFLICT    922    922       E -> G (in Ref. 1; ABQ66268).
FT                                {ECO:0000305}.
FT   CONFLICT   1063   1063       K -> R (in Ref. 1; CAH18093).
FT                                {ECO:0000305}.
FT   CONFLICT   1417   1417       M -> V (in Ref. 1; CAD97851).
FT                                {ECO:0000305}.
FT   CONFLICT   1799   1799       R -> G (in Ref. 1; CAD97851).
FT                                {ECO:0000305}.
FT   CONFLICT   1936   1936       L -> P (in Ref. 1; CAH18093).
FT                                {ECO:0000305}.
FT   CONFLICT   2198   2200       SNL -> RTV (in Ref. 6; AAF14861).
FT                                {ECO:0000305}.
FT   CONFLICT   2358   2358       Q -> R (in Ref. 1; ABQ66268).
FT                                {ECO:0000305}.
FT   TURN        830    832       {ECO:0000244|PDB:4J8S}.
FT   TURN        838    840       {ECO:0000244|PDB:4J8S}.
FT   HELIX       841    856       {ECO:0000244|PDB:4J8S}.
FT   HELIX       866    877       {ECO:0000244|PDB:4J8S}.
FT   HELIX       882    897       {ECO:0000244|PDB:4J8S}.
FT   HELIX       899    904       {ECO:0000244|PDB:4J8S}.
FT   HELIX       907    922       {ECO:0000244|PDB:4J8S}.
FT   HELIX       929    942       {ECO:0000244|PDB:4J8S}.
FT   HELIX       949    961       {ECO:0000244|PDB:4J8S}.
FT   HELIX       962    967       {ECO:0000244|PDB:4J8S}.
FT   HELIX       969    976       {ECO:0000244|PDB:4J8S}.
FT   HELIX       981    983       {ECO:0000244|PDB:4J8S}.
FT   HELIX       986    996       {ECO:0000244|PDB:4J8S}.
FT   HELIX      1076   1082       {ECO:0000244|PDB:4CT4}.
FT   HELIX      1093   1104       {ECO:0000244|PDB:4CRW}.
FT   TURN       1108   1110       {ECO:0000244|PDB:4CRW}.
FT   HELIX      1111   1121       {ECO:0000244|PDB:4CRW}.
FT   HELIX      1124   1126       {ECO:0000244|PDB:4CRW}.
FT   HELIX      1127   1137       {ECO:0000244|PDB:4CRW}.
FT   TURN       1138   1141       {ECO:0000244|PDB:4CRW}.
FT   HELIX      1143   1145       {ECO:0000244|PDB:4CRW}.
FT   HELIX      1146   1156       {ECO:0000244|PDB:4CRW}.
FT   HELIX      1159   1177       {ECO:0000244|PDB:4CRW}.
FT   HELIX      1186   1202       {ECO:0000244|PDB:4CRW}.
FT   HELIX      1204   1206       {ECO:0000244|PDB:4CRW}.
FT   TURN       1212   1214       {ECO:0000244|PDB:4CRW}.
FT   HELIX      1217   1227       {ECO:0000244|PDB:4CRW}.
FT   HELIX      1229   1243       {ECO:0000244|PDB:4CRW}.
FT   HELIX      1244   1248       {ECO:0000244|PDB:4CRW}.
FT   TURN       1250   1252       {ECO:0000244|PDB:4CRW}.
FT   HELIX      1257   1271       {ECO:0000244|PDB:4CRW}.
FT   HELIX      1277   1289       {ECO:0000244|PDB:4CRW}.
FT   HELIX      1294   1296       {ECO:0000244|PDB:4CRW}.
FT   HELIX      1302   1304       {ECO:0000244|PDB:4CRW}.
FT   HELIX      1306   1310       {ECO:0000244|PDB:4CRW}.
FT   HELIX      1359   1361       {ECO:0000244|PDB:4CRU}.
FT   HELIX      1367   1369       {ECO:0000244|PDB:4CRU}.
FT   HELIX      1371   1373       {ECO:0000244|PDB:4CRU}.
FT   HELIX      1381   1385       {ECO:0000244|PDB:4CRU}.
FT   HELIX      1387   1392       {ECO:0000244|PDB:4CRU}.
FT   HELIX      1393   1427       {ECO:0000244|PDB:4CRU}.
FT   TURN       1428   1430       {ECO:0000244|PDB:4CRU}.
FT   HELIX      1434   1476       {ECO:0000244|PDB:4CRU}.
FT   HELIX      1482   1522       {ECO:0000244|PDB:4CRU}.
FT   HELIX      1524   1535       {ECO:0000244|PDB:4CRU}.
FT   HELIX      1543   1552       {ECO:0000244|PDB:4CRU}.
FT   HELIX      1555   1557       {ECO:0000244|PDB:4CRU}.
FT   STRAND     1561   1563       {ECO:0000244|PDB:4CRU}.
FT   HELIX      1566   1569       {ECO:0000244|PDB:4CRU}.
FT   HELIX      1570   1577       {ECO:0000244|PDB:4CRU}.
FT   HELIX      1848   1865       {ECO:0000244|PDB:4CQO}.
FT   HELIX      1870   1885       {ECO:0000244|PDB:4CQO}.
FT   STRAND     1888   1891       {ECO:0000244|PDB:4CQO}.
FT   HELIX      1892   1915       {ECO:0000244|PDB:4CQO}.
FT   HELIX      1926   1948       {ECO:0000244|PDB:4CQO}.
FT   STRAND     1950   1954       {ECO:0000244|PDB:4CQO}.
FT   HELIX      1957   1981       {ECO:0000244|PDB:4CQO}.
FT   HELIX      1982   1984       {ECO:0000244|PDB:4CQO}.
FT   HELIX      1988   2000       {ECO:0000244|PDB:4CQO}.
FT   HELIX      2006   2009       {ECO:0000244|PDB:4CQO}.
FT   HELIX      2012   2025       {ECO:0000244|PDB:4CQO}.
FT   TURN       2028   2030       {ECO:0000244|PDB:4CQO}.
FT   HELIX      2032   2034       {ECO:0000244|PDB:4CQO}.
FT   HELIX      2035   2042       {ECO:0000244|PDB:4CQO}.
FT   HELIX      2045   2052       {ECO:0000244|PDB:4CQO}.
FT   HELIX      2056   2058       {ECO:0000244|PDB:4CQO}.
FT   HELIX      2061   2080       {ECO:0000244|PDB:4CQO}.
FT   HELIX      2086   2105       {ECO:0000244|PDB:4CQO}.
FT   HELIX      2107   2112       {ECO:0000244|PDB:4CQO}.
FT   HELIX      2114   2120       {ECO:0000244|PDB:4CQO}.
FT   HELIX      2126   2133       {ECO:0000244|PDB:4CQO}.
FT   STRAND     2145   2147       {ECO:0000244|PDB:4C0D}.
FT   HELIX      2152   2154       {ECO:0000244|PDB:4CQO}.
FT   HELIX      2157   2159       {ECO:0000244|PDB:4CQO}.
FT   HELIX      2168   2171       {ECO:0000244|PDB:4CQO}.
FT   HELIX      2174   2186       {ECO:0000244|PDB:4CQO}.
FT   HELIX      2191   2200       {ECO:0000244|PDB:4CQO}.
FT   STRAND     2205   2207       {ECO:0000244|PDB:4C0D}.
FT   STRAND     2208   2210       {ECO:0000244|PDB:4CQO}.
FT   HELIX      2212   2232       {ECO:0000244|PDB:4CQO}.
FT   TURN       2239   2241       {ECO:0000244|PDB:4CQO}.
FT   STRAND     2242   2245       {ECO:0000244|PDB:4CQO}.
FT   HELIX      2246   2257       {ECO:0000244|PDB:4CQO}.
FT   HELIX      2260   2271       {ECO:0000244|PDB:4CQO}.
FT   STRAND     2276   2278       {ECO:0000244|PDB:4CQO}.
FT   HELIX      2279   2293       {ECO:0000244|PDB:4CQO}.
FT   STRAND     2296   2298       {ECO:0000244|PDB:4CQO}.
FT   HELIX      2299   2312       {ECO:0000244|PDB:4CQO}.
FT   STRAND     2313   2316       {ECO:0000244|PDB:4CQO}.
FT   HELIX      2320   2331       {ECO:0000244|PDB:4CQO}.
FT   HELIX      2337   2339       {ECO:0000244|PDB:4CQO}.
FT   TURN       2342   2344       {ECO:0000244|PDB:4CQO}.
FT   HELIX      2348   2360       {ECO:0000244|PDB:4CQO}.
SQ   SEQUENCE   2376 AA;  266939 MW;  937A0899537BA615 CRC64;
     MNLDSLSLAL SQISYLVDNL TKKNYRASQQ EIQHIVNRHG PEADRHLLRC LFSHVDFSGD
     GKSSGKDFHQ TQFLIQECAL LITKPNFIST LSYAIDNPLH YQKSLKPAPH LFAQLSKVLK
     LSKVQEVIFG LALLNSSSSD LRGFAAQFIK QKLPDLLRSY IDADVSGNQE GGFQDIAIEV
     LHLLLSHLLF GQKGAFGVGQ EQIDAFLKTL RRDFPQERCP VVLAPLLYPE KRDILMDRIL
     PDSGGVAKTM MESSLADFMQ EVGYGFCASI EECRNIIVQF GVREVTAAQV ARVLGMMART
     HSGLTDGIPL QSISAPGSGI WSDGKDKSDG AQAHTWNVEV LIDVLKELNP SLNFKEVTYE
     LDHPGFQIRD SKGLHNVVYG IQRGLGMEVF PVDLIYRPWK HAEGQLSFIQ HSLINPEIFC
     FADYPCHTVA TDILKAPPED DNREIATWKS LDLIESLLRL AEVGQYEQVK QLFSFPIKHC
     PDMLVLALLQ INTSWHTLRH ELISTLMPIF LGNHPNSAII LHYAWHGQGQ SPSIRQLIMH
     AMAEWYMRGE QYDQAKLSRI LDVAQDLKAL SMLLNGTPFA FVIDLAALAS RREYLKLDKW
     LTDKIREHGE PFIQACMTFL KRRCPSILGG LAPEKDQPKS AQLPPETLAT MLACLQACAG
     SVSQELSETI LTMVANCSNV MNKARQPPPG VMPKGRPPSA SSLDAISPVQ IDPLAGMTSL
     SIGGSAAPHT QSMQGFPPNL GSAFSTPQSP AKAFPPLSTP NQTTAFSGIG GLSSQLPVGG
     LGTGSLTGIG TGALGLPAVN NDPFVQRKLG TSGLNQPTFQ QSKMKPSDLS QVWPEANQHF
     SKEIDDEANS YFQRIYNHPP HPTMSVDEVL EMLQRFKDST IKREREVFNC MLRNLFEEYR
     FFPQYPDKEL HITACLFGGI IEKGLVTYMA LGLALRYVLE ALRKPFGSKM YYFGIAALDR
     FKNRLKDYPQ YCQHLASISH FMQFPHHLQE YIEYGQQSRD PPVKMQGSIT TPGSIALAQA
     QAQAQVPAKA PLAGQVSTMV TTSTTTTVAK TVTVTRPTGV SFKKDVPPSI NTTNIDTLLV
     ATDQTERIVE PPENIQEKIA FIFNNLSQSN MTQKVEELKE TVKEEFMPWV SQYLVMKRVS
     IEPNFHSLYS NFLDTLKNPE FNKMVLNETY RNIKVLLTSD KAAANFSDRS LLKNLGHWLG
     MITLAKNKPI LHTDLDVKSL LLEAYVKGQQ ELLYVVPFVA KVLESSIRSV VFRPPNPWTM
     AIMNVLAELH QEHDLKLNLK FEIEVLCKNL ALDINELKPG NLLKDKDRLK NLDEQLSAPK
     KDVKQPEELP PITTTTTSTT PATNTTCTAT VPPQPQYSYH DINVYSLAGL APHITLNPTI
     PLFQAHPQLK QCVRQAIERA VQELVHPVVD RSIKIAMTTC EQIVRKDFAL DSEESRMRIA
     AHHMMRNLTA GMAMITCREP LLMSISTNLK NSFASALRTA SPQQREMMDQ AAAQLAQDNC
     ELACCFIQKT AVEKAGPEMD KRLATEFELR KHARQEGRRY CDPVVLTYQA ERMPEQIRLK
     VGGVDPKQLA VYEEFARNVP GFLPTNDLSQ PTGFLAQPMK QAWATDDVAQ IYDKCITELE
     QHLHAIPPTL AMNPQAQALR SLLEVVVLSR NSRDAIAALG LLQKAVEGLL DATSGADADL
     LLRYRECHLL VLKALQDGRA YGSPWCNKQI TRCLIECRDE YKYNVEAVEL LIRNHLVNMQ
     QYDLHLAQSM ENGLNYMAVA FAMQLVKILL VDERSVAHVT EADLFHTIET LMRINAHSRG
     NAPEGLPQLM EVVRSNYEAM IDRAHGGPNF MMHSGISQAS EYDDPPGLRE KAEYLLREWV
     NLYHSAAAGR DSTKAFSAFV GQMHQQGILK TDDLITRFFR LCTEMCVEIS YRAQAEQQHN
     PAANPTMIRA KCYHNLDAFV RLIALLVKHS GEATNTVTKI NLLNKVLGIV VGVLLQDHDV
     RQSEFQQLPY HRIFIMLLLE LNAPEHVLET INFQTLTAFC NTFHILRPTK APGFVYAWLE
     LISHRIFIAR MLAHTPQQKG WPMYAQLLID LFKYLAPFLR NVELTKPMQI LYKGTLRVLL
     VLLHDFPEFL CDYHYGFCDV IPPNCIQLRN LILSAFPRNM RLPDPFTPNL KVDMLSEINI
     APRILTNFTG VMPPQFKKDL DSYLKTRSPV TFLSDLRSNL QVSNEPGNRY NLQLINALVL
     YVGTQAIAHI HNKGSTPSMS TITHSAHMDI FQNLAVDLDT EGRYLFLNAI ANQLRYPNSH
     THYFSCTMLY LFAEANTEAI QEQITRVLLE RLIVNRPHPW GLLITFIELI KNPAFKFWNH
     EFVHCAPEIE KLFQSVAQCC MGQKQAQQVM EGTGAS
//
